Barclays’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.6M | Buy |
496,030
+794
| +0.2% | +$7.37K | ﹤0.01% | 1691 |
|
|
2025
Q1 | $3.63M | Buy |
495,236
+163,994
| +50% | +$1.2M | ﹤0.01% | 1623 |
|
|
2024
Q4 | $2.83M | Sell |
331,242
-180,280
| -35% | -$1.54M | ﹤0.01% | 1991 |
|
|
2024
Q3 | $4.45M | Buy |
511,522
+138,441
| +37% | +$1.2M | ﹤0.01% | 1611 |
|
|
2024
Q2 | $2.55M | Buy |
373,081
+11,988
| +3% | +$82K | ﹤0.01% | 1545 |
|
|
2024
Q1 | $3.29M | Buy |
361,093
+250,987
| +228% | +$2.28M | ﹤0.01% | 1602 |
|
|
2023
Q4 | $491K | Buy |
110,106
+84,143
| +324% | +$375K | ﹤0.01% | 3010 |
|
|
2023
Q3 | $81K | Buy |
25,963
+4,840
| +23% | +$15.1K | ﹤0.01% | 3404 |
|
|
2023
Q2 | $109K | Sell |
21,123
-258,564
| -92% | -$1.33M | ﹤0.01% | 3359 |
|
|
2023
Q1 | $1.47M | Sell |
279,687
-39,147
| -12% | -$206K | ﹤0.01% | 1863 |
|
|
2022
Q4 | $896K | Buy |
318,834
+315,567
| +9,659% | +$887K | ﹤0.01% | 2214 |
|
|
2022
Q3 | $14K | Sell |
3,267
-13,102
| -80% | -$56.1K | ﹤0.01% | 4061 |
|
|
2022
Q2 | $66K | Sell |
16,369
-16,112
| -50% | -$65K | ﹤0.01% | 3634 |
|
|
2022
Q1 | $161K | Sell |
32,481
-92,831
| -74% | -$460K | ﹤0.01% | 3443 |
|
|
2021
Q4 | $873K | Buy |
125,312
+49,575
| +65% | +$345K | ﹤0.01% | 2275 |
|
|
2021
Q3 | $757K | Buy |
75,737
+59,369
| +363% | +$593K | ﹤0.01% | 2397 |
|
|
2021
Q2 | $231K | Sell |
16,368
-49,263
| -75% | -$695K | ﹤0.01% | 2830 |
|
|
2021
Q1 | $1.08M | Buy |
65,631
+43,203
| +193% | +$709K | ﹤0.01% | 2256 |
|
|
2020
Q4 | $464K | Sell |
22,428
-8,019
| -26% | -$166K | ﹤0.01% | 2357 |
|
|
2020
Q3 | $231K | Buy |
30,447
+876
| +3% | +$6.65K | ﹤0.01% | 2663 |
|
|
2020
Q2 | $246K | Buy |
29,571
+15,542
| +111% | +$129K | ﹤0.01% | 2699 |
|
|
2020
Q1 | $70K | Sell |
14,029
-28,436
| -67% | -$142K | ﹤0.01% | 2956 |
|
|
2019
Q4 | $168K | Sell |
42,465
-13,732
| -24% | -$54.3K | ﹤0.01% | 3255 |
|
|
2019
Q3 | $171K | Sell |
56,197
-9,566
| -15% | -$29.1K | ﹤0.01% | 3132 |
|
|
2019
Q2 | $290K | Buy |
65,763
+42,885
| +187% | +$189K | ﹤0.01% | 2999 |
|
|
2019
Q1 | $91K | Buy |
22,878
+649
| +3% | +$2.58K | ﹤0.01% | 3380 |
|
|
2018
Q4 | $88K | Sell |
22,229
-25,117
| -53% | -$99.4K | ﹤0.01% | 3014 |
|
|
2018
Q3 | $325K | Buy |
47,346
+23,254
| +97% | +$160K | ﹤0.01% | 2834 |
|
|
2018
Q2 | $162K | Sell |
24,092
-4,170
| -15% | -$28K | ﹤0.01% | 2844 |
|
|
2018
Q1 | $184K | Buy |
28,262
+24,148
| +587% | +$157K | ﹤0.01% | 2884 |
|
|
2017
Q4 | $18K | Sell |
4,114
-4,406
| -52% | -$19.3K | ﹤0.01% | 3730 |
|
|
2017
Q3 | $52K | Buy |
8,520
+7,713
| +956% | +$47.1K | ﹤0.01% | 2935 |
|
|
2017
Q2 | $7K | Sell |
807
-32,449
| -98% | -$281K | ﹤0.01% | 3492 |
|
|
2017
Q1 | $308K | Buy |
33,256
+29,983
| +916% | +$278K | ﹤0.01% | 2247 |
|
|
2016
Q4 | $27K | Buy |
3,273
+2,975
| +998% | +$24.5K | ﹤0.01% | 3009 |
|
|
2016
Q3 | $2K | Sell |
298
-3,607
| -92% | -$24.2K | ﹤0.01% | 3618 |
|
|
2016
Q2 | $20K | Buy |
3,905
+1,877
| +93% | +$9.61K | ﹤0.01% | 2815 |
|
|
2016
Q1 | $18K | Sell |
2,028
-3,209
| -61% | -$28.5K | ﹤0.01% | 2813 |
|
|
2015
Q4 | $47K | Sell |
5,237
-822
| -14% | -$7.38K | ﹤0.01% | 2515 |
|
|
2015
Q3 | $85K | Buy |
6,059
+1,330
| +28% | +$18.7K | ﹤0.01% | 2423 |
|
|
2015
Q2 | $99K | Buy |
4,729
+4,556
| +2,634% | +$95.4K | ﹤0.01% | 2366 |
|
|
2015
Q1 | $7K | Sell |
173
-2,454
| -93% | -$99.3K | ﹤0.01% | 3553 |
|
|
2014
Q4 | $61K | Buy |
+2,627
| New | +$61K | ﹤0.01% | 2906 |
|